Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s Form 4 filing
Natures Sunshine Products Inc (NATR) · filed Oct 15, 2024
- Accession no.
- 0001104659-24-108390
- Filed
- Oct 15, 2024
- Trade date
- Sep 6-Oct 14, 2024
- Filing delay
- 39 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. Open-market sales total $145.2K. It was filed 39 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.CIK 0001615258 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Common Stock | JOtherAcquired | +2,968 | $0.00 | $0 | 77,362 | Indirect | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −1,399 | $13.54 | −$18,942.46 | 75,963 | Indirect | |
| Oct 8, 2024 | Common Stock | SSaleDisposed | −1,800 | $13.13 | −$23,634 | 74,163 | Indirect | |
| Oct 9, 2024 | Common Stock | SSaleDisposed | −1,816 | $13.36 | −$24,261.76 | 72,347 | Indirect | |
| Oct 10, 2024 | Common Stock | SSaleDisposed | −3,000 | $13.39 | −$40,170 | 69,347 | Indirect | |
| Oct 11, 2024 | Common Stock | SSaleDisposed | −1,580 | $13.37 | −$21,124.6 | 67,767 | Indirect | |
| Oct 14, 2024 | Common Stock | SSaleDisposed | −1,300 | $13.12 | −$17,056 | 66,467 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.